Bill116th CongressFiled Sep 9, 2019Health
H.R. 4244
MAGIC Act
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it doesSummary introduced in house (Sep 9, 2019)
Market Access for Generic Insulin Competition or the MAGIC Act
This bill provides a pathway for the Food and Drug Administration to approve chemically synthesized insulin or an analogue of chemically synthesized insulin as a generic drug under the abbreviated new drug application process.
What just happenedSep 10, 2019
Referred to the Subcommittee on Health.
Who’s behind it
Rep. Kelly, Mike [R-PA-16](R-PA)Sponsor
4 cosponsors4 R
4cosponsors1committees4actions6subjects
- Introduced in HouseSep 9, 2019
- Sep 10, 2019Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Sep 9, 2019IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Sep 9, 2019IntroReferralIntro-H
Introduced in House
- Sep 9, 2019IntroReferral1000
Introduced in House